Clubhouse App: @frankdolan
Frank has spent over twenty years in biopharmaceuticals serving in commercial leadership roles. At Takeda, Amylin, and Acadia Pharmaceuticals he was a founding member of the team that brought them from R&D-only into launch-ready commercial organizations. His 15 product launches include large market brands such as Lipitor to orphan drug portfolios.
Frank’s strong record of increasing company value has resulted in company acquisitions of over $100 billion.
Podcast Interviews on Life Science Marketing Radio
How Does a New Biotech Company Successfully Launch Its First Product?
Elevating Innovation and Trust in Life Science
Thank you for your interest